Compass Therapeutics, Inc. — Director's Dealing 2020

Jun 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Compass Therapeutics, Inc. (NONE)
CIK: 0001738021
Period of Report: 2020-06-19

Reporting Person: Sunderland Julie (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-19	Common Stock	P	289118	$5.00	Acquired	2502025	Indirect

Footnotes

F1: These shares are held directly by Biomatics Capital Partners, LP. The Reporting Person is a member of the Issuer's board of directors, the co-founder of and a managing partner at Biomatics Capital Partners, and exercises shared voting and investment power of the securities held by Biomatics Capital Partners, LP.